is an investigational drug derived from shark cartilage that is not currently approved by the FDA for standard medical use. Because it is an investigational agent, it is generally not available for purchase as an over-the-counter product or through standard retail pharmacies. Current Availability and How to Buy
Neovastat (Æ-941) in refractory renal cell carcinoma patients buy neovastat ae-941
General "shark cartilage" products are sold as dietary supplements, but Neovastat is a specific, standardized extract (AE-941) that differs from typical over-the-counter shark cartilage powders. Complete Write-Up: What is Neovastat? is an investigational drug derived from shark cartilage
While you cannot buy the drug itself directly, professional drug profiles and historical data can be purchased from information providers like AdisInsight . Complete Write-Up: What is Neovastat
Neovastat is a liquid extract of marine cartilage developed primarily by AEterna Zentaris . It was designed to target cancer through its antiangiogenic properties—essentially trying to "starve" tumors by preventing the growth of new blood vessels.
Neovastat is primarily used in clinical trials.
is an investigational drug derived from shark cartilage that is not currently approved by the FDA for standard medical use. Because it is an investigational agent, it is generally not available for purchase as an over-the-counter product or through standard retail pharmacies. Current Availability and How to Buy
Neovastat (Æ-941) in refractory renal cell carcinoma patients
General "shark cartilage" products are sold as dietary supplements, but Neovastat is a specific, standardized extract (AE-941) that differs from typical over-the-counter shark cartilage powders. Complete Write-Up: What is Neovastat?
While you cannot buy the drug itself directly, professional drug profiles and historical data can be purchased from information providers like AdisInsight .
Neovastat is a liquid extract of marine cartilage developed primarily by AEterna Zentaris . It was designed to target cancer through its antiangiogenic properties—essentially trying to "starve" tumors by preventing the growth of new blood vessels.
Neovastat is primarily used in clinical trials.